- Home
- ORMP vs NKTX Comparison
ORMP vs NKTX Comparison
Compare ORMP & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- NKTX
- Stock Information
- Founded
- ORMP 2002
- NKTX 2015
- Country
- ORMP United States
- NKTX United States
- Employees
- ORMP N/A
- NKTX N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- NKTX Biotechnology: Pharmaceutical Preparations
- Sector
- ORMP Health Care
- NKTX Health Care
- Exchange
- ORMP Nasdaq
- NKTX Nasdaq
- Market Cap
- ORMP 104.6M
- NKTX 123.5M
- IPO Year
- ORMP N/A
- NKTX 2020
- Fundamental
- Price
- ORMP $2.43
- NKTX $2.08
- Analyst Decision
- ORMP
- NKTX Strong Buy
- Analyst Count
- ORMP 0
- NKTX 5
- Target Price
- ORMP N/A
- NKTX $13.50
- AVG Volume (30 Days)
- ORMP 120.6K
- NKTX 773.5K
- Earning Date
- ORMP 11-06-2025
- NKTX 11-06-2025
- Dividend Yield
- ORMP N/A
- NKTX N/A
- EPS Growth
- ORMP N/A
- NKTX N/A
- EPS
- ORMP N/A
- NKTX N/A
- Revenue
- ORMP $2,000,000.00
- NKTX N/A
- Revenue This Year
- ORMP N/A
- NKTX N/A
- Revenue Next Year
- ORMP N/A
- NKTX N/A
- P/E Ratio
- ORMP N/A
- NKTX N/A
- Revenue Growth
- ORMP N/A
- NKTX N/A
- 52 Week Low
- ORMP $1.82
- NKTX $1.31
- 52 Week High
- ORMP $3.09
- NKTX $4.55
- Technical
- Relative Strength Index (RSI)
- ORMP 53.62
- NKTX 48.52
- Support Level
- ORMP $2.37
- NKTX $2.10
- Resistance Level
- ORMP $2.57
- NKTX $2.24
- Average True Range (ATR)
- ORMP 0.15
- NKTX 0.10
- MACD
- ORMP -0.01
- NKTX 0.01
- Stochastic Oscillator
- ORMP 37.00
- NKTX 50.00
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.